Skip to main content

Table 4 Highest level of respiratory support and adjunctive therapies among neonates with composite respiratory morbidity

From: Short-term respiratory outcomes in late preterm infants

 

34

35

36

LPI

37

38

39

40

41

TI

 

n = 38

n = 38

n = 29

n = 105

n = 32

n = 28

n = 19

n = 28

n = 14

n = 121

Nasal oxygen**

0 (0.0)

1 (2.6)

2 (6.9)

3 (2.9)

5 (15.6)

2 (7.1)

3 (15.8)

5 (17.9)

3 (21.4)

18 (14.9)

N-CPAP***

26 (68.4)

26 (68.4)

16 (55.2)

68 (64.8)

13 (40.6)

11 (39.3)

6 (31.6)

4 (14.3)

5 (35.7)

39 (32.2)

MV

7 (18.4)

4 (10.5)

2 (6.9)

13 (12.4)

5 (15.6)

2 (7.1)

2 (10.5)

5 (17.9)

2 (14.3)

16 (13.2)

Surfactant*

6 (15.8)

7 (18.4)

4 (13.8)

17 (16.2)

5 (15.6)

0 (0.0)

0 (0.0)

3 (10.7)

0 (0.0)

8 (6.6)

INO

0 (0.0)

2 (5.3)

2 (6.9)

4 (3.8)

3 (9.4)

0 (0.0)

0 (0.0)

2 (7.1)

0 (0.0)

5 (4.1)

Pleural drainage

6 (15.8)

1 (2.6)

1 (3.5)

8 (7.6)

5 (15.6)

1 (3.6)

0 (0.0)

1 (3.6)

1(7.1)

8 (6.6)

Data are expressed as absolute numbers and proportions (%) of observed data in each category. All tests refer to comparisons between late preterm infants (LPI) and term infants (TI).

  1. ***P < .001, using χ2or Fisher test as appropriate.
  2. **P < .01, using χ2or Fisher test as appropriate.
  3. *P < .05, using χ2or Fisher test as appropriate.